FI54916B - Foerfarande foer framstaellning av terapeutiskt verksamma n-substituerade 2-pyrrolidoner - Google Patents
Foerfarande foer framstaellning av terapeutiskt verksamma n-substituerade 2-pyrrolidonerInfo
- Publication number
- FI54916B FI54916B FI383/71A FI38371A FI54916B FI 54916 B FI54916 B FI 54916B FI 383/71 A FI383/71 A FI 383/71A FI 38371 A FI38371 A FI 38371A FI 54916 B FI54916 B FI 54916B
- Authority
- FI
- Finland
- Prior art keywords
- pyrrolidoner
- nutritional
- substitute
- framework
- therapeutic treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB697870A GB1309692A (en) | 1970-02-13 | 1970-02-13 | N-substituted lactams |
Publications (2)
Publication Number | Publication Date |
---|---|
FI54916B true FI54916B (fi) | 1978-12-29 |
FI54916C FI54916C (fi) | 1979-04-10 |
Family
ID=9824325
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI383/71A FI54916C (fi) | 1970-02-13 | 1971-02-10 | Foerfarande foer framstaellning av terapeutiskt verksamma n-substituerade 2-pyrrolidoner |
Country Status (15)
Country | Link |
---|---|
JP (2) | JPS535301B1 (fi) |
BE (1) | BE762728R (fi) |
CH (1) | CH530395A (fi) |
CS (2) | CS167911B2 (fi) |
DE (1) | DE2106418C2 (fi) |
DK (1) | DK137451B (fi) |
ES (1) | ES388135A2 (fi) |
FI (1) | FI54916C (fi) |
FR (1) | FR2081508B2 (fi) |
GB (1) | GB1309692A (fi) |
MY (1) | MY7400072A (fi) |
NL (1) | NL168830C (fi) |
SU (2) | SU508186A3 (fi) |
YU (2) | YU34876B (fi) |
ZA (1) | ZA71877B (fi) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1045043B (it) * | 1975-08-13 | 1980-04-21 | Isf Spa | Derivati pirrolidinici |
GB1583871A (en) * | 1976-10-19 | 1981-02-04 | Ucb Sa | Anti-aggregants |
BE864269A (fr) * | 1977-03-03 | 1978-06-16 | Parke Davis & Co | Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire |
ATE27T1 (de) * | 1978-05-08 | 1981-04-15 | Ucb Sa | Lactam-n-essigsaeuren und ihre amide, verfahren zu ihrer herstellung und heilmittel, die sie enthalten |
IT1141287B (it) * | 1979-06-13 | 1986-10-01 | Nattermann A & Cie | Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono |
FR2515179A1 (fr) * | 1981-07-24 | 1983-04-29 | Hoffmann La Roche | Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique |
EP0089900B1 (en) * | 1982-03-24 | 1985-12-27 | Prodes S.A. | New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts |
GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
GB8412358D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
DE3420193A1 (de) * | 1984-05-30 | 1985-12-05 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel |
US4804400A (en) * | 1986-09-12 | 1989-02-14 | Ciba-Geigy Corporation | N-phenyl-maleimides and herbicidal and plant growth regulating methods of use thereof |
GB8827389D0 (en) * | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
TW544311B (en) * | 1998-08-06 | 2003-08-01 | Daiichi Seiyaku Co | Therapeutic or preventive agent for intractable epilepsies |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
US6686477B2 (en) | 2000-09-29 | 2004-02-03 | Eastman Chemical Company | Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
EP1395560A1 (en) | 2001-05-23 | 2004-03-10 | Ucb, S.A. | 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders |
ATE410412T1 (de) | 2001-08-10 | 2008-10-15 | Ucb Pharma Sa | Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen |
MXPA04002714A (es) * | 2001-10-08 | 2004-07-05 | Ucb Sa | Uso de derivados de 2-oxo-1-pirrolidina para el tratamiento de trastornos del movimiento y de la discinesia. |
US7132552B2 (en) | 2003-02-03 | 2006-11-07 | Teva Pharmaceutical Industries, Ltd. | Process for producing levetiracetam |
ES2214147B1 (es) | 2003-02-28 | 2005-10-01 | Farma-Lepori S.A. | Procedimiento de obtencion de un agente antiepileptico. |
CA2497062A1 (en) | 2004-02-18 | 2005-08-18 | Dr. Reddy's Laboratories Limited | Preparation of amino acid amides |
CA2488325C (en) | 2004-11-22 | 2010-08-24 | Apotex Pharmachem Inc. | Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
WO2006095362A1 (en) * | 2005-03-10 | 2006-09-14 | Rubamin Limited | Process for preparing levetiracetam |
US8183241B2 (en) | 2005-06-01 | 2012-05-22 | Ucb Pharma, S.A. | 2-oxo-1-pyrrolidine derivatives |
EP2147911A1 (en) | 2008-07-24 | 2010-01-27 | ZaCh System S.p.A. | Process for the preparation of levetiracetam |
DK3260118T3 (da) | 2008-10-16 | 2021-04-19 | Univ Johns Hopkins | Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion |
US8785661B2 (en) | 2009-05-13 | 2014-07-22 | Nektar Therapeutics | Oligome-containing pyrrolidine compounds |
US7939676B2 (en) | 2009-09-17 | 2011-05-10 | Zach System S.P.A. | Process for the preparation of levetiracetam |
CA2789014C (en) | 2010-02-09 | 2019-01-15 | Michela Gallagher | Methods and compositions for improving cognitive function |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
DK3431106T3 (da) | 2014-01-21 | 2021-03-15 | Janssen Pharmaceutica Nv | Kombinationer omfattende positive allosteriske modulatorer eller orthosteriske agonister af metabotrop glutamaterg subtype 2-receptor og anvendelse af disse |
ES2860298T3 (es) | 2014-01-21 | 2021-10-04 | Janssen Pharmaceutica Nv | Combinaciones que comprenden moduladores alostéricos positivos del receptor glutamatérgico metabotrópico de subtipo 2 y su uso |
CN104059010A (zh) * | 2014-06-12 | 2014-09-24 | 浙江华海药业股份有限公司 | 一种制备2-(2-氧代吡咯烷-1-基)-丁酸酯的方法 |
CN106591179B (zh) * | 2016-12-05 | 2018-07-03 | 长兴制药股份有限公司 | 甲基包囊菌及其在选择性拆分制备(S)-α-乙基-2-氧-1-吡咯烷乙酸盐上的应用 |
RU2663899C1 (ru) * | 2017-07-19 | 2018-08-13 | Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" | Способ получения 1-карбамоилметил-4-фенил-2-пирролидона |
US11384050B1 (en) | 2021-02-03 | 2022-07-12 | Vitaworks Ip, Llc | Method for preparing levetiracetam and intermediates thereof |
WO2024039886A1 (en) | 2022-08-19 | 2024-02-22 | Agenebio, Inc. | Benzazepine derivatives, compositions, and methods for treating cognitive impairment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1039113A (en) * | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
-
1970
- 1970-02-13 GB GB697870A patent/GB1309692A/en not_active Expired
-
1971
- 1971-02-08 FR FR7104195A patent/FR2081508B2/fr not_active Expired
- 1971-02-09 NL NLAANVRAGE7101697,A patent/NL168830C/xx not_active IP Right Cessation
- 1971-02-10 ES ES388135A patent/ES388135A2/es not_active Expired
- 1971-02-10 FI FI383/71A patent/FI54916C/fi active
- 1971-02-10 BE BE762728A patent/BE762728R/xx active
- 1971-02-10 CS CS987A patent/CS167911B2/cs unknown
- 1971-02-10 YU YU306/71A patent/YU34876B/xx unknown
- 1971-02-10 DK DK59571AA patent/DK137451B/da not_active IP Right Cessation
- 1971-02-11 DE DE2106418A patent/DE2106418C2/de not_active Expired
- 1971-02-11 ZA ZA710877A patent/ZA71877B/xx unknown
- 1971-02-11 CH CH200171A patent/CH530395A/fr not_active IP Right Cessation
- 1971-02-12 SU SU1893858A patent/SU508186A3/ru active
- 1971-02-12 SU SU1621307A patent/SU508185A3/ru active
- 1971-02-12 JP JP612471A patent/JPS535301B1/ja active Pending
- 1971-12-10 CS CS140674A patent/CS167912B2/cs unknown
-
1974
- 1974-12-31 MY MY197472A patent/MY7400072A/xx unknown
-
1977
- 1977-11-07 JP JP13335277A patent/JPS53130656A/ja active Granted
-
1978
- 1978-06-19 YU YU01445/78A patent/YU144578A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPS535301B1 (fi) | 1978-02-25 |
JPS5420491B2 (fi) | 1979-07-23 |
DK137451C (fi) | 1978-07-24 |
NL7101697A (fi) | 1971-08-17 |
DE2106418C2 (de) | 1983-12-22 |
JPS53130656A (en) | 1978-11-14 |
MY7400072A (en) | 1974-12-31 |
YU144578A (en) | 1982-10-31 |
DK137451B (da) | 1978-03-06 |
SU508186A3 (ru) | 1976-03-25 |
FR2081508A2 (fi) | 1971-12-03 |
YU34876B (en) | 1980-04-30 |
GB1309692A (en) | 1973-03-14 |
NL168830B (nl) | 1981-12-16 |
ES388135A2 (es) | 1973-05-01 |
CS167912B2 (fi) | 1976-05-28 |
FI54916C (fi) | 1979-04-10 |
ZA71877B (en) | 1971-10-27 |
SU508185A3 (ru) | 1976-03-25 |
BE762728R (fr) | 1971-08-10 |
NL168830C (nl) | 1982-05-17 |
CS167911B2 (fi) | 1976-05-28 |
DE2106418A1 (de) | 1971-08-19 |
FR2081508B2 (fi) | 1975-06-06 |
YU30671A (en) | 1979-10-31 |
CH530395A (fr) | 1972-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI54916C (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma n-substituerade 2-pyrrolidoner | |
SE387861B (sv) | Apparat for forangningsbehandling av vetskor | |
SE393381B (sv) | Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat | |
FI54301C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat | |
SE390304B (sv) | Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin | |
SE384529B (sv) | Apparat for behandling av djurhudar eller liknande | |
FI55184B (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma fenyl-2-pyrrolidinoner samt deras isomerer | |
SE388422B (sv) | Forfarande for reduktion av theabin | |
BE776863A (fr) | Redistribution des alkylhydrosilanes | |
FI54100B (fi) | Foerfarande foer framstaellning av terapeutiskt vaerdefulla tricykliska foereningar | |
DOP1971001881A (es) | Tratamiento de dientes | |
FI54104C (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma pyrrolidinonfoereningar | |
FI54602B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 6-amidinopenicillansyraderivat | |
FI55988C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara o-acylfenoletanolaminer | |
FI53967B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara bensobicykloalkanaminer | |
FI55503C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrimidinonderivat | |
FI53700C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara diaminopropiofenonderivat | |
FI53819B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara n-lysergyl-3-aminopyridiner | |
FI55338B (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma n-metyl-imidazoler | |
SE382051B (sv) | Forfarande for framstellning av 3-sulfonamid-4-hydroxifenyl-2-piperidylkarbinoler | |
FI56171B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva asylerade piperidin-, tetrahydropyridin- och pyridinderivat | |
FI56179C (fi) | Foerfarande foer framstaellning av terapeutiskt verksamma imidazolderivat | |
BE774241A (fr) | Procede et compositions therapeutiques | |
FI55172C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara polyenfoereningar | |
ZA70319B (en) | Medicine suitable for the treatment of ailments of the prostrate gland |